UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor

The Journal of pharmacology and experimental therapeutics, 2006-08, Vol.318 (2), p.657

2006

Volltextzugriff (PDF)

Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties

The Journal of pharmacology and experimental therapeutics, 2005-09, Vol.314 (3), p.1274

2005

Volltextzugriff (PDF)

Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Aβ and tau neuropathology in the triple-transgenic mice

Molecular psychiatry, 2015-11, Vol.20 (11), p.1329-1338

2015

Volltextzugriff (PDF)

β-lactamase inhibitors display anti-seizure properties in an invertebrate assay

Neuroscience, 2010-09, Vol.169 (4), p.1800-1804

2010

Volltextzugriff (PDF)

Design, Synthesis, and Preclinical Characterization of Novel, Highly Selective Indole Estrogens

Journal of medicinal chemistry, 2001-05, Vol.44 (11), p.1654-1657

2001

Volltextzugriff (PDF)

Synthesis and SAR of Adatanserin: Novel Adamantyl Aryl- and Heteroarylpiperazines with Dual Serotonin 5-HT1A and 5-HT2 Activity as Potential Anxiolytic and Antidepressant Agents

Journal of medicinal chemistry, 1999-12, Vol.42 (25), p.5077-5094

1999

Volltextzugriff (PDF)

Tiplaxtinin, a Novel, Orally Efficacious Inhibitor of Plasminogen Activator Inhibitor-1: Design, Synthesis, and Preclinical Characterization

Journal of medicinal chemistry, 2004-07, Vol.47 (14), p.3491-3494

2004

Volltextzugriff (PDF)

Design, Synthesis, SAR, and Biological Evaluation of Highly Potent Benzimidazole-Spaced Phosphono-α-Amino Acid Competitive NMDA Antagonists of the AP-6 Type

Journal of medicinal chemistry, 2001-05, Vol.44 (10), p.1516-1529

2001

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of Thio-Containing Compounds with Serum HDL-Cholesterol-Elevating Properties

Journal of medicinal chemistry, 2004-01, Vol.47 (3), p.681-695

2004

Volltextzugriff (PDF)

Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, A[beta] and tau neuropathology in the triple-transgenic mice

Molecular psychiatry, 2015-11, Vol.20 (11), p.1329

2015

Volltextzugriff (PDF)

The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist

The Journal of pharmacology and experimental therapeutics, 2000-02, Vol.292 (2), p.584

2000

Volltextzugriff (PDF)

Preclinical profile of the pyrimidinylpiperazinyl imide compound WY-47,846: A potential anxiolytic

Drug development research, 1989, Vol.18 (1), p.29-45

1989

Volltextzugriff (PDF)

Synthesis and Biological Evaluation of Benzodioxanylpiperazine Derivatives as Potent Serotonin 5-HT1A Antagonists: The Discovery of Lecozotan

Journal of medicinal chemistry, 2005-05, Vol.48 (10), p.3467-3470

2005

Volltextzugriff (PDF)

Design and Synthesis of [2-(8,9-Dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)- ethyl]phosphonic Acid (EAA-090), a Potent N-Methyl-d-aspartate Antagonist, via the Use of 3-Cyclobutene-1,2-dione as an Achiral α-Amino Acid Bioisostere

Journal of medicinal chemistry, 1998-01, Vol.41 (2), p.236-246

1998

Volltextzugriff (PDF)

b-lactamase inhibitors display anti-seizure properties in an invertebrate assay

Neuroscience, 2010-09, Vol.169 (4), p.1800-1804

2010

Volltextzugriff (PDF)

New Generation Dopaminergic Agents. 1. Discovery of a Novel Scaffold Which Embraces the D2 Agonist Pharmacophore. Structure−Activity Relationships of a Series of 2-(Aminomethyl)chromans

Journal of medicinal chemistry, 1997-12, Vol.40 (26), p.4235-4256

1997

Volltextzugriff (PDF)

New Generation Dopaminergic Agents. 1. Discovery of a Novel Scaffold Which Embraces the D 2 Agonist Pharmacophore. Structure−Activity Relationships of a Series of 2-(Aminomethyl)chromans

Journal of medicinal chemistry, 1997-12, Vol.40 (26), p.4235-4256

1997

Volltextzugriff (PDF)

New generation dopaminergic agents 4. Exploiting the 2-methyl chroman scaffold. Synthesis and evaluation of two novel series of 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano[2,3-e]indole and indol-8-one derivatives

Tetrahedron, 1998-06, Vol.54 (25), p.7081-7108

1998

Volltextzugriff (PDF)

Discovery of a highly potent, functionally-selective muscarinic M1 agonist, way-132983 using rational drug design and receptor modelling

Bioorganic & medicinal chemistry letters, 1999-07, Vol.9 (14), p.1895-1900

1999

Volltextzugriff (PDF)

Discovery of a highly potent, functionally-selective muscarinic M 1 agonist,WAY-132983 using rational drug design and receptor modelling

Bioorganic & medicinal chemistry letters, 1999-07, Vol.9 (14), p.1895-1900

1999

Volltextzugriff (PDF)

New Antihistamines: Substituted Piperazine and Piperidine Derivatives as Novel H1-Antagonists

Journal of medicinal chemistry, 1995-09, Vol.38 (20), p.4026-4032

1995

Volltextzugriff (PDF)

ChemInform Abstract: New Antihistamines: Substituted Piperazine and Piperidine Derivatives as Novel H1-Antagonists

ChemInform, 1996-01, Vol.27 (4), p.no-no

1996

Volltextzugriff (PDF)

Synthesis and structure-activity relationship of substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones: potential anxiolytic agents

Journal of medicinal chemistry, 1989-05, Vol.32 (5), p.1024-1033

1989

Volltextzugriff (PDF)

A convenient synthesis of NG-mono[14C-methyl]-L-arginine

Journal of labelled compounds & radiopharmaceuticals, 1981-06, Vol.18 (6), p.777-779

1981

Volltextzugriff (PDF)

Antipsychotic activity of substituted .gamma.-carbolines

Journal of medicinal chemistry, 1987-10, Vol.30 (10), p.1818-1823

1987

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(114)
Buchkapitel
(1)

Sprache

Englisch
(115)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor

Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties

Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Aβ and tau neuropathology in the triple-transgenic mice

β-lactamase inhibitors display anti-seizure properties in an invertebrate assay

Design, Synthesis, and Preclinical Characterization of Novel, Highly Selective Indole Estrogens

Synthesis and SAR of Adatanserin: Novel Adamantyl Aryl- and Heteroarylpiperazines with Dual Serotonin 5-HT1A and 5-HT2 Activity as Potential Anxiolytic and Antidepressant Agents

Tiplaxtinin, a Novel, Orally Efficacious Inhibitor of Plasminogen Activator Inhibitor-1: Design, Synthesis, and Preclinical Characterization

Design, Synthesis, SAR, and Biological Evaluation of Highly Potent Benzimidazole-Spaced Phosphono-α-Amino Acid Competitive NMDA Antagonists of the AP-6 Type

Design, Synthesis, and Biological Evaluation of Thio-Containing Compounds with Serum HDL-Cholesterol-Elevating Properties

Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, A[beta] and tau neuropathology in the triple-transgenic mice

The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist

Preclinical profile of the pyrimidinylpiperazinyl imide compound WY-47,846: A potential anxiolytic

Synthesis and Biological Evaluation of Benzodioxanylpiperazine Derivatives as Potent Serotonin 5-HT1A Antagonists: The Discovery of Lecozotan

Design and Synthesis of [2-(8,9-Dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)- ethyl]phosphonic Acid (EAA-090), a Potent N-Methyl-d-aspartate Antagonist, via the Use of 3-Cyclobutene-1,2-dione as an Achiral α-Amino Acid Bioisostere

b-lactamase inhibitors display anti-seizure properties in an invertebrate assay

New Generation Dopaminergic Agents. 1. Discovery of a Novel Scaffold Which Embraces the D2 Agonist Pharmacophore. Structure−Activity Relationships of a Series of 2-(Aminomethyl)chromans

New Generation Dopaminergic Agents. 1. Discovery of a Novel Scaffold Which Embraces the D 2 Agonist Pharmacophore. Structure−Activity Relationships of a Series of 2-(Aminomethyl)chromans

New generation dopaminergic agents 4. Exploiting the 2-methyl chroman scaffold. Synthesis and evaluation of two novel series of 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano[2,3-e]indole and indol-8-one derivatives

Discovery of a highly potent, functionally-selective muscarinic M1 agonist, way-132983 using rational drug design and receptor modelling

Discovery of a highly potent, functionally-selective muscarinic M 1 agonist,WAY-132983 using rational drug design and receptor modelling

New Antihistamines: Substituted Piperazine and Piperidine Derivatives as Novel H1-Antagonists

ChemInform Abstract: New Antihistamines: Substituted Piperazine and Piperidine Derivatives as Novel H1-Antagonists

Synthesis and structure-activity relationship of substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones: potential anxiolytic agents

A convenient synthesis of NG-mono[14C-methyl]-L-arginine

Antipsychotic activity of substituted .gamma.-carbolines

Suchergebnisse filtern